Sonoma Biotherapeutic’s breakroom overlooks Seattle’s Elliott Bay. (GeekWire Photo / Lisa Stiffler) One of the research spaces in Sonoma Biotherapeutic’s R&D center in Seattle.

Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company has signed a 10-year lease in the 501 building for more than 83,000 square feet.

Sonoma Biotherapeutics Receives $45 Million Milestone Payment from Regeneron under Ongoing Collaboration September 04, 2024 08:00 AM Eastern Daylight Time ...